Feasibility of double sleeve lobectomy after neoadjuvant chemotherapy in patients with non-small-cell lung cancer.
Yi BaoChao JiangZiwei WanYang WangYifan ZhongJiajun DengYunlang SheLei JiangXuefei HuYuming ZhuBentong YuChang ChenPublished in: Interactive cardiovascular and thoracic surgery (2022)
The intraoperative performance and postoperative outcomes of double sleeve lobectomy following neoadjuvant chemotherapy were similar to direct surgery, indicating that double sleeve lobectomy after neoadjuvant chemotherapy is feasible and safe in central lung cancer involving both the pulmonary artery and bronchus.
Keyphrases
- neoadjuvant chemotherapy
- pulmonary artery
- locally advanced
- lymph node
- coronary artery
- sentinel lymph node
- pulmonary hypertension
- pulmonary arterial hypertension
- patients undergoing
- minimally invasive
- rectal cancer
- squamous cell carcinoma
- coronary artery bypass
- radiation therapy
- thoracic surgery
- type diabetes
- acute coronary syndrome
- metabolic syndrome
- coronary artery disease